MIVI Neuroscience
PrivateLast Round
Debt
May 15, 2024
Total Funding Raised
$87.64M
Company Overview
MIVI Neuroscience operates in Healthcare & Life Sciences and is based in Eden Prairie, Minnesota. Its latest recorded funding round was a Debt round in May 2024.
MIVI Neuroscience is a healthcare company that develops and commercializes innovative clinical solutions and medical devices for neuro-interventional procedures to improve stroke treatment outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MIVI Neuroscience Comparables
Compare MIVI Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perfuze | 90% | |
| Q'Apel Medical | 88% | |
| RapidPulse | 88% |
For institutional investors. Book with your work email.
MIVI Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 15, 2024 | ||||
| Series B | Jan 21, 2021 | ||||
| Series A | Mar 19, 2020 | ||||
| Series A | May 14, 2019 | ||||
| Seed | Sep 7, 2017 | ||||
Seed | Mar 17, 2017 |
For institutional investors. Book with your work email.
MIVI Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B |
| Aphelion Capital | Series B |
| Perceptive Advisors | Series B |
| Concord Health Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2024
$9.25M debt round completed.
- Mar 19, 2020
$20M round completed.
For institutional investors. Book with your work email.
MIVI Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MIVI Neuroscience's valuation, stock price, and market status.
Is MIVI Neuroscience a public or private company?
MIVI Neuroscience is a private company.
What is the current stock price of MIVI Neuroscience?
MIVI Neuroscience is a private company, so its shares have no public market price. Caplight tracks MIVI Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MIVI Neuroscience worth (valuation)?
Valuation information for MIVI Neuroscience is not publicly available.
Can I buy MIVI Neuroscience stock?
MIVI Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MIVI Neuroscience's last funding round?
MIVI Neuroscience's most recent funding round was Debt on May 15, 2024.
Who are the main investors in MIVI Neuroscience?
Key investors in MIVI Neuroscience include Deerfield Management, Aphelion Capital, Perceptive Advisors, Concord Health Partners.
Will MIVI Neuroscience IPO soon?
No public IPO plans have been announced for MIVI Neuroscience.
How can I track MIVI Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in MIVI Neuroscience's shares on secondary markets.